Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuangteng Jingu Pian is a Traditional Chinese Medicine (TCM) herbal formulation developed and marketed by Shaanxi Momentum Qixuehe Pharmaceutical. It is administered as an oral tablet and is indicated for the treatment of arthralgia (joint pain), heaviness, restricted movement, and fatigue, particularly when symptoms are aggravated by cold exposure. In the framework of Traditional Chinese Medicine, the product functions to dispel wind, remove dampness, scatter cold, relieve pain, and invigorate blood circulation to dredge collaterals. As a complex herbal mixture, its specific molecular targets and pharmacological mechanisms of action are not defined in Western pharmaceutical terms. The product is currently approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shuangteng Jingu Pian.